CMBA
RETA

C.M. Bidwell & Associates’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

C.M. Bidwell & Associates’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,450
Closed -$51K – 472
2018
Q2 		$51K Buy
+1,450
New +$51K 0.05% 243